CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 123 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $118,000 | -50.8% | 19,984 | 0.0% | 0.01% | -54.8% |
| Q2 2019 | $240,000 | -0.4% | 19,984 | 0.0% | 0.03% | 0.0% |
| Q1 2019 | $241,000 | -28.3% | 19,984 | 0.0% | 0.03% | -39.2% |
| Q4 2018 | $336,000 | +13.1% | 19,984 | 0.0% | 0.05% | +21.4% |
| Q3 2018 | $297,000 | -11.6% | 19,984 | 0.0% | 0.04% | -17.6% |
| Q2 2018 | $336,000 | -26.6% | 19,984 | 0.0% | 0.05% | -30.1% |
| Q1 2018 | $458,000 | -11.4% | 19,984 | 0.0% | 0.07% | -5.2% |
| Q4 2017 | $517,000 | +75.3% | 19,984 | 0.0% | 0.08% | +67.4% |
| Q3 2017 | $295,000 | +5.7% | 19,984 | 0.0% | 0.05% | +4.5% |
| Q2 2017 | $279,000 | -18.2% | 19,984 | 0.0% | 0.04% | -18.5% |
| Q1 2017 | $341,000 | +65.5% | 19,984 | 0.0% | 0.05% | +74.2% |
| Q4 2016 | $206,000 | +36.4% | 19,984 | +33.4% | 0.03% | +34.8% |
| Q3 2016 | $151,000 | -10.1% | 14,984 | 0.0% | 0.02% | -4.2% |
| Q2 2016 | $168,000 | -18.0% | 14,984 | 0.0% | 0.02% | -14.3% |
| Q1 2016 | $205,000 | -27.8% | 14,984 | 0.0% | 0.03% | -30.0% |
| Q4 2015 | $284,000 | +1.1% | 14,984 | 0.0% | 0.04% | -14.9% |
| Q3 2015 | $281,000 | – | 14,984 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |